Company: BIVIW
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001520138-25-000144
Chunk: 8

Company: BIOVIE INC.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 8
---

     -  
     -  
     -  
     -  
     (7,112,529) 
     (7,112,529)

    Balance, December 31, 2024 
     18,478,307  
     7,456  
     369,781,837  
     (26,326) 
     (27) 
     -  
     (345,866,687) 
     23,922,579 

    Stock-based compensation - stock options 
     -  
     -  
     338,412  
     -  
     -  
     -  
     -  
     338,412 

    Stock-based compensation - restricted stock units and restricted shares 
     -  
     -  
     345,372  
     -  
     -  
     -  
     -  
     345,372 

    Issuance of common stock from vesting of - restricted stock units 
     67,428  
     7  
     (5) 
     (2,033) 
     (2) 
     -  
     -  
     - 

    Net Loss 
     -  
     -  
     -  
     -  
     -  
     -  
     (2,788,418) 
     (2,788,418)

    Balance, March 31, 2025 
     18,545,735  
    $7,463  
    $370,465,616  
     (28,359) 
    $(29) 
    $-  
    $(348,655,105) 
    $21,817,945 

See accompanying notes to unaudited condensed financial
statements

 6 

BioVie Inc.

Condensed Statements of Cash Flows

(Unaudited) 

    Nine Months Ended  
    Nine Months Ended 

    March 31, 2025  
    March 31, 2024 

    CASH FLOWS FROM OPERATING ACTIVITIES: 

    Net loss 
    $(14,052,979) 
    $(27,179,739